What is Pluton Biosciences?
Pluton Biosciences operates at the intersection of advanced microbiology and modern agronomy. The company is pioneering a sun-powered biological nutrient delivery mechanism that aligns nutrient release with specific crop demand cycles. By minimizing nutrient runoff and enhancing uptake efficiency, Pluton Bio provides a scalable, sustainable alternative to traditional synthetic fertilizers. Their market position is bolstered by a commitment to integrating these biological pathways into existing farming practices, ensuring that growers can achieve higher yields without compromising environmental integrity. As the agricultural sector faces increasing pressure to adopt sustainable practices, Pluton Bio's technology serves as a critical bridge between high-performance farming and ecological stewardship.
How much funding has Pluton Biosciences raised?
Pluton Biosciences has raised a total of $23.1M across 2 funding rounds:
Angel/Seed
$6.6M
Series A
$16.5M
Angel/Seed (2021): $6.6M with participation from Better Ventures, The Yield Lab Institute, Wing Venture Capital, The Grantham Foundation, First In Ventures, and Fall Line Capital
Series A (2023): $16.5M led by RA Capital Management, First In Ventures, Fall Line Capital, Illumina Ventures, and The Grantham Foundation
Key Investors in Pluton Biosciences
RA Capital Management
A multi-stage investment manager focused on evidence-based investing in life science companies, with a strategic interest in climate and sustainability technologies.
Fall Line Capital
An investment firm specializing in the intersection of farmland management and agricultural technology to drive untapped productivity.
Illumina Ventures
A leader in genomics and precision health investing, dedicated to translating scientific innovation into impactful solutions for life sciences.
What's next for Pluton Biosciences?
With the recent influx of capital, Pluton Biosciences is well-positioned to accelerate the commercialization of its biological nutrient platform. The company is expected to deepen its collaboration with strategic partners to refine its delivery systems and expand its footprint across diverse agricultural landscapes. Future growth will likely focus on scaling manufacturing capabilities and conducting large-scale field trials to validate the efficacy of their nutrient pathways in varied climates. By leveraging its strong investor base, Pluton Bio is poised to transition from a research-intensive development phase to a broader market deployment, setting a new standard for efficiency in the global agtech sector.
See full Pluton Biosciences company page
